Brazil Orders 12.5 Million mRNA COVID-19 Vaccines

Moderna, Inc. today announced a contract with Brazil's Ministry of Health (Ministério da Saúde) to supply its monovalent mRNA COVID-19 vaccine.

Under the new contract, 12.5 million doses of Moderna's mRNA COVID-19 vaccine (SpikeVax) are anticipated for delivery in the second quarter of 2024.

This contract follows the Brazilian Health Regulatory Agency's approval of Moderna's COVID-19 vaccine (XBB.1.5 sublineage) in March 2024 to prevent COVID-19 in children from six months of age and adults.

"We are proud to partner with the Ministry of Health to provide our mRNA COVID-19 vaccine for the first time in Brazil as part of the national vaccination campaign," said Stéphane Bancel, Chief Executive Officer of Moderna, in a press release on April 22, 2024.

"This agreement underscores our commitment to global health and our role in supporting Brazil's efforts to protect its citizens against COVID-19."

"We look forward to working with the Ministry of Health to help maintain health security in Brazil."

Previously, Moderna generated preclinical and clinical data of its monovalent XBB.1.5 vaccine candidate, which showed an immune response against XBB sublineages and currently circulating strains of the SARS-CoV-2 virus, including JN.1.